XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

Realtime	Geld	Brief	Zeit
	4,900	4,970	17:57
	4,890	4,970	17:57

Realtime

Geld

Brief

Zeit

4,900

4,970

17:57

4,890

4,970

17:57

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 17.10.2025

The following instruments on Boerse Frankfurt do have their last trading day on 17.10.2025
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 17.10.2025

ISIN Name
CA54020J1XXX LODESTAR METALS CORP.
GB00B02QNXXX PAYPOINT PLC LS -,0033
GB0004726XXX SPIRENT COMMUNIC.LS-,0333
JE00BQC4YXXX WNS HOLDINGS LTD. LS-,1
SE0007789XXX XBRANE BIOPHARMA AB
USU2203CAXXX COTY 21/26 REGS
US00808Y5XXX AETHLON MED. NEW DL-,001
US3134003017 FED. HOME LN MTGE O.N.
US61747YEXXX MORGAN STANL 22/26 FLR
US81727U1XXX SENSEONICS HLGS.INC.-,001
US84856M2XXX SPIR.COMMUN.ADR/ LS-,0333

SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen

Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!

Hier klicken

Zeit	Aktuelle Nachrichten
Mo	AETHLON MEDICAL INC - S-1, General form for registration of securities
11.06.	Aethlon outlines Cohort 3 expansion to 3-6 patients as Hemopurifier oncology trial advances
10.06.	AETHLON MEDICAL INC - S-8, Securities to be offered to employees in employee benefit plans
10.06.	AETHLON MEDICAL INC - 10-K, Annual Report
10.06.	Aethlon Medical reports FY results

Zeit

Aktuelle Nachrichten

AETHLON MEDICAL INC - S-1, General form for registration of securities

11.06.

Aethlon outlines Cohort 3 expansion to 3-6 patients as Hemopurifier oncology trial advances

10.06.

AETHLON MEDICAL INC - S-8, Securities to be offered to employees in employee benefit plans

10.06.

AETHLON MEDICAL INC - 10-K, Annual Report

10.06.

Aethlon Medical reports FY results

Zeit	Aktuelle Nachrichten
Mo	Krieg, KI, Energie: Die 14-Billionen-Dollar-Welle rollt an	© Foto: Global Travel Images - Travelstock44Ein gigantischer Investitions-Boom rollt an, doch den globalen Aktien wird das nicht viel helfen, sagen Top-Investoren und schichten lieber in andere Anlagen... ► Artikel lesen
Do	Freddie Mac: Mortgage Rates Decline
16.06.	Fannie Mae, Freddie Mac cut to Neutral at BTIG on lack of release visibility
16.06.	BTIG downgrades Freddie Mac stock rating on conservatorship uncertainty
11.06.	Freddie Mac: Mortgage Rates Average 6.52%

Zeit

Aktuelle Nachrichten

Krieg, KI, Energie: Die 14-Billionen-Dollar-Welle rollt an

© Foto: Global Travel Images - Travelstock44Ein gigantischer Investitions-Boom rollt an, doch den globalen Aktien wird das nicht viel helfen, sagen Top-Investoren und schichten lieber in andere Anlagen...
► Artikel lesen

Freddie Mac: Mortgage Rates Decline

16.06.

Fannie Mae, Freddie Mac cut to Neutral at BTIG on lack of release visibility

16.06.

BTIG downgrades Freddie Mac stock rating on conservatorship uncertainty

11.06.

Freddie Mac: Mortgage Rates Average 6.52%

Zeit	Aktuelle Nachrichten
Mo	Lodestar Metals Corp (2): Lodestar Metals hires Zacks for research coverage
Mo	Lodestar Metals Corp.: Lodestar Engages Zacks Research	Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) (FSE: PR90) ("Lodestar" or the "Company") is pleased to announce that it has entered... ► Artikel lesen
16.06.	Unfassbar: SpaceX und der Gold-Traum! Alphabet, Agnico-Eagle, B2Gold, LodeStar Metals und Advanced Gold Exploration	An den Finanzmärkten zeichnet sich derzeit ein ungewöhnliches Bild ab: Nahezu alle Anlageklassen stehen unter Druck. Ob Edelmetalle wie Gold und Silber, klassische Industriebranchen oder Zukunftsthemen... ► Artikel lesen
10.06.	Lodestar Metals Corp (2): Lodestar Metals shares now trading on OTCQB Market
09.06.	Stocks in Play: Lodestar Metals Corp.

Zeit

Aktuelle Nachrichten

Lodestar Metals Corp (2): Lodestar Metals hires Zacks for research coverage

Lodestar Metals Corp.: Lodestar Engages Zacks Research

Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Lodestar Metals Corp. (TSXV: LSTR) (OTCQB: SVTNF) (FSE: PR90) ("Lodestar" or the "Company") is pleased to announce that it has entered...
► Artikel lesen

16.06.

Unfassbar: SpaceX und der Gold-Traum! Alphabet, Agnico-Eagle, B2Gold, LodeStar Metals und Advanced Gold Exploration

An den Finanzmärkten zeichnet sich derzeit ein ungewöhnliches Bild ab: Nahezu alle Anlageklassen stehen unter Druck. Ob Edelmetalle wie Gold und Silber, klassische Industriebranchen oder Zukunftsthemen...
► Artikel lesen

10.06.

Lodestar Metals Corp (2): Lodestar Metals shares now trading on OTCQB Market

09.06.

Stocks in Play: Lodestar Metals Corp.

Zeit	Aktuelle Nachrichten
11:42	PayPoint plc: Director/PDMR Shareholding
10:06	PayPoint plc: PayPoint completes acquisition of AperiData, strengthening its Open Banking capabilities	PayPoint completes acquisition of AperiData, strengthening its Open Banking capabilities PayPoint has announced it has completed the acquisition of AperiData following a previous £1 million strategic... ► Artikel lesen
16.06.	PayPoint plc: Director/PDMR Shareholding
12.06.	PayPoint Plc Reports Climb In Full Year Income
11.06.	PayPoint backs restructuring plan as annual profit jumps

Zeit

Aktuelle Nachrichten

11:42

PayPoint plc: Director/PDMR Shareholding

10:06

PayPoint plc: PayPoint completes acquisition of AperiData, strengthening its Open Banking capabilities

PayPoint completes acquisition of AperiData, strengthening its Open Banking capabilities PayPoint has announced it has completed the acquisition of AperiData following a previous £1 million strategic...
► Artikel lesen

16.06.

PayPoint plc: Director/PDMR Shareholding

12.06.

PayPoint Plc Reports Climb In Full Year Income

11.06.

PayPoint backs restructuring plan as annual profit jumps

Zeit	Aktuelle Nachrichten
10.06.	Senseonics, Welldoc partner on next-gen Eversense 365 app development
10.06.	Senseonics Holdings, Inc.: Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense 365
08.06.	Senseonics Holdings, Inc. - 8-K, Current Report
06.06.	Senseonics Holdings, Inc.: Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems
01.06.	Senseonics Holdings, Inc.: Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Zeit

Aktuelle Nachrichten

10.06.

Senseonics, Welldoc partner on next-gen Eversense 365 app development

10.06.

Senseonics Holdings, Inc.: Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense 365

08.06.

Senseonics Holdings, Inc. - 8-K, Current Report

06.06.

Senseonics Holdings, Inc.: Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

01.06.

Senseonics Holdings, Inc.: Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Zeit	Aktuelle Nachrichten
11.06.	Xbrane Biopharma AB: Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane - Xbrane's Biosimilar Candidate to Darzalex (Daratumumab)	Solna, Sweden and Richmond, CA, US - Xbrane Biopharma AB ("Xbrane"), a Sweden-based biotechnology company focused on the development of biosimilars, and JOINN Biologics US Inc. ("JOINN"), a US-based... ► Artikel lesen
05.05.	Xbrane Biopharma AB: Announcement from the annual general meeting in Xbrane Biopharma AB	The annual general meeting 2026 (the "AGM") of Xbrane Biopharma AB ("Xbrane" or the "Company") was held today on 5 May 2026 and the following resolutions were passed by the meeting. Adoption of the... ► Artikel lesen
05.05.	Xbrane Biopharma AB: Xbrane and its partner Intas agree on revised financing arrangement for Xbrane's Xdivane development activities	Xbrane and its strategic partner Intas Pharmaceuticals Ltd. ("Intas") have agreed on revised terms relating to the financing of Xbrane's CMC-related development activities for Xdivane, a biosimilar... ► Artikel lesen
30.04.	Xbrane Biopharma AB: Xbrane Submits Ranibizumab Biosimilar Candidate To FDA	Xbrane Biopharma AB (Nasdaq Stockholm: XBRANE) has submitted an application for approval (BLA) to the U.S. Food and Drug Administration for its biosimilar candidate to LUCENTIS (ranibizumab). The original... ► Artikel lesen
31.03.	Xbrane Biopharma AB: Xbrane provides an update on the timeline for resubmission of the market authorization application in the United States	Xbrane Biopharma AB (publ) announces today that the company intends to resubmit its Biologics License Application (BLA) for the ranibizumab biosimilar to the U.S. Food and Drug Administration (FDA)... ► Artikel lesen

Zeit

Aktuelle Nachrichten

11.06.

Xbrane Biopharma AB: Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane - Xbrane's Biosimilar Candidate to Darzalex (Daratumumab)

Solna, Sweden and Richmond, CA, US - Xbrane Biopharma AB ("Xbrane"), a Sweden-based biotechnology company focused on the development of biosimilars, and JOINN Biologics US Inc. ("JOINN"), a US-based...
► Artikel lesen

05.05.

Xbrane Biopharma AB: Announcement from the annual general meeting in Xbrane Biopharma AB

The annual general meeting 2026 (the "AGM") of Xbrane Biopharma AB ("Xbrane" or the "Company") was held today on 5 May 2026 and the following resolutions were passed by the meeting. Adoption of the...
► Artikel lesen

05.05.

Xbrane Biopharma AB: Xbrane and its partner Intas agree on revised financing arrangement for Xbrane's Xdivane development activities

Xbrane and its strategic partner Intas Pharmaceuticals Ltd. ("Intas") have agreed on revised terms relating to the financing of Xbrane's CMC-related development activities for Xdivane, a biosimilar...
► Artikel lesen

30.04.

Xbrane Biopharma AB: Xbrane Submits Ranibizumab Biosimilar Candidate To FDA

Xbrane Biopharma AB (Nasdaq Stockholm: XBRANE) has submitted an application for approval (BLA) to the U.S. Food and Drug Administration for its biosimilar candidate to LUCENTIS (ranibizumab). The original...
► Artikel lesen

31.03.

Xbrane Biopharma AB: Xbrane provides an update on the timeline for resubmission of the market authorization application in the United States

Xbrane Biopharma AB (publ) announces today that the company intends to resubmit its Biologics License Application (BLA) for the ranibizumab biosimilar to the U.S. Food and Drug Administration (FDA)...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
AETHLON MEDICAL INC	1,280	-5,88 %
FEDERAL HOME LOAN MORTGAGE CORPORATION	5,000	+1,21 %
LODESTAR METALS CORP	0,031	-8,82 %
PAYPOINT PLC	6,750	0,00 %
SENSEONICS HOLDINGS INC	5,450	+2,83 %
XBRANE BIOPHARMA AB	0,900	0,00 %

Unternehmen / Aktien

Kurs

AETHLON MEDICAL INC

1,280

-5,88 %

FEDERAL HOME LOAN MORTGAGE CORPORATION

5,000

+1,21 %

LODESTAR METALS CORP

0,031

-8,82 %

PAYPOINT PLC